Search - tctmd.com

Displaying 121 - 140 of 148

Sort: Relevancy | Date

Presentation TCT 2014

The Cost of TAVR: Association Between Length of Stay and the Cost of Transfemoral Transcatheter Aortic Valve Replacement in Medicare Patients

Presenter: Christopher Meduri

September 16, 2014

Presentation TCT 2014

Landscape Highlights of New Transfemoral Access-Closure Devices

Presenter: Alexandre Abizaid

September 15, 2014

Presentation TCT 2014

Case #2: Transfemoral TAVR for Bicuspid Aortic Valve Stenosis Using a Second-Generation Device

Presenter: Graham A. Cassel, Hans R. Figulla, Greg L. Kaluza, Jochen Wöhrle, Peter Boekstegers

September 14, 2014

Presentation TCT 2014

TCT 687: One-Year Outcomes of Transfemoral Transcatheter Versus Surgical Aortic Valve Replacement in Patients with Intermediate Surgical Risk: The Italian OBSERVANT Study

Presenter: Martin B. Leon, Neil E. Moat, Ariel Finkelstein, Marco Barbanti

September 13, 2014

Presentation

Factors Associated with Vascular Complications in Balloon-Expandable Transfemoral TAVR via Open vs Percutaneous Approaches

Presenter: M.B. Kadakia

July 18, 2014

Presentation TVT 2014

Direct Aortic TAVR: Indications, Optimal Technique, and Outcomes

Presenter: Michael J. Reardon

June 07, 2014

Presentation TVT 2014

Transapical TAVR: Indications, Optimal Technique, and Outcomes

Presenter: Joerg Kempfert

June 07, 2014

Presentation TVT 2014

Transfemoral TAVR Access Site Complications: Lessons from the Published Literature

Presenter: Philippe Généreux

June 07, 2014

Presentation TVT 2014

Landscape Highlights of New Transfemoral Access-Closure Devices

Presenter: Eberhard Grube

June 06, 2014

Presentation TVT 2014

Transfemoral, Fully Percutaneous TAVR is Now the Gold Standard!

Presenter: Raj Makkar

June 06, 2014

Presentation

Predicting Vascular Complications in Transfemoral TAVR Using CT: A Novel Area-Based Index

Presenter: 186956|Amar Krishnaswamy

May 06, 2014

Presentation

Frequency, Pattern, and Cause of Fever Following Transfemoral TAVR

Presenter: Eran Leshem-Rubinow

January 09, 2014

Presentation TCT 2013

A Standard Cath Lab Is Adequate for All Transfemoral TAVR Cases!

Presenter: Helene Eltchaninoff

October 31, 2013

Presentation TCT 2013

TCT-113. Clinical and Left Ventricular Functional Outcomes Associated with Cardiac Biomarker Elevation after Transfemoral TAVR: A Sub-analysis from the PARTNER Trial

Presenter: Alan Zajarias

October 29, 2013

Presentation TCT 2013

PARTNER: A Propensity-Matched Comparison of Clinical Outcomes After Transapical vs. Transfemoral TAVR

Presenter: Eugene Blackstone

October 28, 2013

Presentation TVT 2013

Transfemoral TAVR in a patient with Bioprosthetic Mitral valve and LV dysfunction

Presenter: Puvi Seshiah

June 13, 2013

Presentation TVT 2013

The Landscape of Dedicated Transfemoral Closure Devices for TAVR

Presenter: Eberhard Grube

June 12, 2013

Presentation TVT 2013

Best Clinical Practices for Transfemoral TAVR

Presenter: Susheel Kodali

June 12, 2013

Presentation TVT 2013

Access Screening for TAVR: Who Should and Shouldn't Be Transfemoral Candidates

Presenter: Mathew Williams

June 12, 2013

Presentation TCT 2013

TAVR– 3 year results of transapical versus transfemoral approach in a real world population of 1000 patients with severe aortic stenosis

Presenter: G. Schymik, T. Herbinger, A. Wuerth, J.-S. Schymik, P. Bramlage, M. Heimeshoff, T. Sueselbeck, R. Kiefer, B.-D. Gonska, H. Posival, C. Schmitt, H. Schroefel

January 31, 2013

Advertisement

The Cost of TAVR: Association Between Length of Stay and the Cost of Transfemoral Transcatheter Aortic Valve Replacement in Medicare Patients

Landscape Highlights of New Transfemoral Access-Closure Devices

Case #2: Transfemoral TAVR for Bicuspid Aortic Valve Stenosis Using a Second-Generation Device

TCT 687: One-Year Outcomes of Transfemoral Transcatheter Versus Surgical Aortic Valve Replacement in Patients with Intermediate Surgical Risk: The Italian OBSERVANT Study

Factors Associated with Vascular Complications in Balloon-Expandable Transfemoral TAVR via Open vs Percutaneous Approaches

Direct Aortic TAVR: Indications, Optimal Technique, and Outcomes

Transapical TAVR: Indications, Optimal Technique, and Outcomes

Transfemoral TAVR Access Site Complications: Lessons from the Published Literature

Landscape Highlights of New Transfemoral Access-Closure Devices

Transfemoral, Fully Percutaneous TAVR is Now the Gold Standard!

Predicting Vascular Complications in Transfemoral TAVR Using CT: A Novel Area-Based Index

Frequency, Pattern, and Cause of Fever Following Transfemoral TAVR

A Standard Cath Lab Is Adequate for All Transfemoral TAVR Cases!

TCT-113. Clinical and Left Ventricular Functional Outcomes Associated with Cardiac Biomarker Elevation after Transfemoral TAVR: A Sub-analysis from the PARTNER Trial

PARTNER: A Propensity-Matched Comparison of Clinical Outcomes After Transapical vs. Transfemoral TAVR

Transfemoral TAVR in a patient with Bioprosthetic Mitral valve and LV dysfunction

The Landscape of Dedicated Transfemoral Closure Devices for TAVR

Best Clinical Practices for Transfemoral TAVR

Access Screening for TAVR: Who Should and Shouldn't Be Transfemoral Candidates

TAVR– 3 year results of transapical versus transfemoral approach in a real world population of 1000 patients with severe aortic stenosis

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content